DocTalk

Policy expert, Cindy Steinberg, of the US Pain Foundation explains the updated changes that have been proposed by the CDC to the Clinical Guideline for Prescribing Opioids.

Dr. Brandling-Bennett speaks of some of the advancements made by women in health care and what could be done to further support women in the workforce.

Dr. Obi speaks of the disparities associated with the disease, the challenges patients face, and how sarcoidosis – the “great mimicker” as some clinicians have described it- can be differentiated from other diseases.

Featuring insights from Dr. Raj Chovatiya, Dr. Karan Lal and more on what can be done to promote inclusivity and improved care for patients with skin of color.

Sharp candidly discusses the need for new solution ideas to strike while the iron is hot, during this rebuilding stage of the healthcare system.

Dr. Osunkwo details advancements in the field of sickle cell disease, including chronic disease-managing therapies and stem cell transplant and gene therapies.

Cases of the inflammatory heart event occurred 1626 times after an mRNA vaccine dose in US patients from December 2020 to August 2021.

Dr. Mease discusses a recent network meta-analyses that included new phase 3 data on guselkumab.

Dr. Swamy speaks of the history of burnout that preceded the pandemic, and how physicians are struggling with emotional, mental, and physical trauma from COVID-19.

The institute will assemble and support a diverse, multidisciplinary team of scientists and researchers to lead the charge breakthroughs in airway science.

Dr. Ivy speaks on promising new therapies and training for sickle cell management during the first blood shortage in the United States in 10 years.

Dr. Siddharthan speaks of high COPD rates in low- and middle-income countries with increased environmental exposures and a lack of diagnostic tools.

Dr. Talbot speaks to the variety of different strains of influenza, and how research into different flu vaccines could be informed by advancements made in the management of shingles and COVID-19.

Dr. Silverberg speaks of the recent FDA approval of the biologic for patients with moderate-to-severe atopic dermatitis.

Complex ADHD along with other comorbid psychiatric conditions increases the risk of mortality for patients.

Dr. Jellinger discusses the lipid section of the DCRM guidelines, the role of combination therapies in lowering LDL and what is coming next for the field of diabetes in 2022.

Donald Alcendor, PhD, joins to review currently available data surrounding the newest COVID-19 variant of concern, and shares guidance for concerned clinicians and the general public.

The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually.